18.1004.64% ( -0.880 )
Closed: Nov 13, 16:00:00 (EDT)Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: City Therapeutics(CTY) the Revenue is 3.179 M (+13.98%);the EBIT is -25.57 M (-92.27%);the EPS is -4.34 (-57.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B13.98%
----
----
EBIT
-0.03B92.27%
----
----
EPS
-4.337257.20%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 24, 2026
Estimate Revenue7.5 M
Estimate EBIT-23.83 M
Estimate EPS-3.135
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
